DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 107 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$153,931,812
-4.5%
21,231,9740.0%2.56%
-8.7%
Q1 2024$161,150,683
+109.1%
21,231,974
+25.3%
2.80%
+97.0%
Q4 2023$77,083,174
+15.2%
16,941,3570.0%1.42%
-3.5%
Q3 2023$66,918,360
+26.2%
16,941,3570.0%1.47%
+30.2%
Q2 2023$53,026,447
-30.9%
16,941,3570.0%1.13%
-33.8%
Q1 2023$76,744,347
+9.7%
16,941,3570.0%1.71%
+18.2%
Q4 2022$69,967,804
+29.1%
16,941,3570.0%1.45%
+34.2%
Q3 2022$54,212,000
+374.4%
16,941,357
+190.6%
1.08%
+357.2%
Q2 2022$11,427,000
-51.6%
5,830,2490.0%0.24%
-55.3%
Q1 2022$23,613,000
-62.5%
5,830,2490.0%0.53%
-60.0%
Q4 2021$62,908,000
-6.4%
5,830,2490.0%1.32%
+0.5%
Q3 2021$67,223,000
+17.4%
5,830,2490.0%1.31%
+29.0%
Q2 2021$57,253,000
-23.8%
5,830,249
+13.3%
1.02%
-35.6%
Q1 2021$75,162,000
-31.8%
5,144,5390.0%1.58%
-27.4%
Q4 2020$110,145,000
+41.1%
5,144,5390.0%2.18%
+14.6%
Q3 2020$78,043,000
+18.1%
5,144,5390.0%1.90%
-1.3%
Q2 2020$66,107,0005,144,5391.92%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
CHI Advisors LLC 1,515,148$22,985,0008.18%
ACUTA CAPITAL PARTNERS, LLC 830,000$12,591,0003.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,144,539$78,043,0001.90%
Sio Capital Management, LLC 300,591$4,560,0000.90%
Atlas Venture Advisors, Inc. 292,184$4,432,0000.75%
Vivo Capital, LLC 799,662$12,131,0000.70%
Logos Global Management LP 330,000$5,006,0000.64%
Soleus Capital Management, L.P. 76,184$1,156,0000.61%
SPHERA FUNDS MANAGEMENT LTD. 342,064$5,189,0000.51%
RA Capital Management 1,515,151$22,985,0000.42%
View complete list of LARIMAR THERAPEUTICS INC shareholders